U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 1 to 19 of 19

Tests names and labsConditionsGenes, analytes, and microbesMethods

APPL1 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CentoIEM Panel

Centogene AG - the Rare Disease Company
Germany
669688
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Diabetes and Obesity Panel

Centogene AG - the Rare Disease Company
Germany
247262
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

MODY and Neonatal Diabetes Panel, Sequencing

ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories
United States
1723
  • C Sequence analysis of the entire coding region

Invitae Monogenic Diabetes Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
5928
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Monogenic Diabetes Panel

PreventionGenetics, part of Exact Sciences
United States
10154
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Hypoglycemia Panel

PreventionGenetics, part of Exact Sciences
United States
131115
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Maturity-onset diabetes of the young, type 14, 616511, Autosomal dominant; MODY14 (MODY) (APPL1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Maturity Onset Diabetes of the Young (MODY) via the APPL1 Gene

PreventionGenetics, part of Exact Sciences
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Maturity Onset Diabetes of the Young (MODY) Panel

PreventionGenetics, part of Exact Sciences
United States
2018
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

MODY Type 14

Genetiks Genetic Diagnosis Center Genetic Diseases Evaluation Center
Turkey
11
  • C Sequence analysis of the entire coding region

Maturity-Onset Diabetes of the Young (MODY) Expanded Genetic Panel

MNG Laboratories (Medical Neurogenetics, LLC.)
United States
2210
  • C Sequence analysis of the entire coding region

Maturity onset diabetes of the young (MODY) panel

Al Jalila Children’s Genomics Center Al Jalila Childrens Speciality Hospital
United Arab Emirates
1517
  • C Sequence analysis of the entire coding region

Maturity-Onset Diabetes of the Young (MODY) NGS Panel

Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center
United States
1614
  • C Sequence analysis of the entire coding region

MATURITY-ONSET DIABETES OF THE YOUNG (MODY) TYPE 14

Laboratorio de Genetica Clinica SL
Spain
11
  • C Sequence analysis of the entire coding region

APPL1 Sequencing

Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center
United States
11
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Maturity-onset diabetes of the young, type 14

Labor Dr. Wisplinghoff
Germany
11
  • C Sequence analysis of the entire coding region

Maturity-Onset Diabetes of the Young

Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University
United States
1325
  • C Sequence analysis of the entire coding region

Maturity-onset diabetes of the young, type 14

Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders
Germany
11
  • C Sequence analysis of the entire coding region

Results: 1 to 19 of 19

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.